Literature DB >> 8560788

Noncoding control region of naturally occurring BK virus variants: sequence comparison and functional analysis.

U Moens1, T Johansen, J I Johnsen, O M Seternes, T Traavik.   

Abstract

The human polyomavirus BK (BKV) has a proven oncogenic potential, but its contribution to tumorigenesis under natural conditions remains undetermined. As for other primate polyomaviruses, the approximately 5.2 kbp double-stranded circular genome of BKV has three functional regions: the coding regions for the two early (T, t antigens) and four late (agno, capsid proteins; VP1-3) genes separated by a noncoding control region (NCCR). The NCCR contains the origin of replication as well as a promoter/enhancer with a mosaic of cis-acting elements involved in the regulation of both early and late transcription. Since the original isolation of BKV in 1971, a number of other strains have been identified. Most strains reveal a strong sequence conservation in the protein coding regions of the genome, while the NCCR exhibits considerable variation between different BKV isolates. This variation is due to deletions, duplications, and rearrangements of a basic set of sequence blocks. Comparative studies have proven that the anatomy of the NCCR may determine the transcriptional activities governed by the promoter/enhancer, the host cell tropism and permissivity, as well as the oncogenic potential of a given BKV strain. In most cases, however, the NCCR sequence of new isolates was determined after the virus had been passaged several times in more or less arbitrarily chosen cell cultures, a process known to predispose for NCCR rearrangements. Following the development of the polymerase chain reaction (PCR), it has become feasible to obtain naturally occurring BKV NCCRs, and their sequences, in samples taken directly from infected human individuals. Hence, the biological significance of BKV NCCR variation may be studied without prior propagation of the virus in cell culture. Such variation has general interest, because the BKV NCCRs represent typical mammalian promoter/enhancers, with a large number of binding motifs for cellular transacting factors, which can be conveniently handled for experimental purposes. This communication reviews the naturally occurring BKV NCCR variants, isolated and sequenced directly from human samples, that have been reported so far. The sequences of the different NCCRs are compared and analyzed for the presence of proven and putative cellular transcription factor binding sites. Differences in biological properties between BKV variants are discussed in light of their aberrant NCCR anatomies and the potentially modifying influence of transacting factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560788     DOI: 10.1007/bf01701816

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  107 in total

Review 1.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  Proteins of the nuclear factor-1 family act as an activator of the late promoter in human polyomavirus BK in vitro.

Authors:  T Chakraborty; G C Das
Journal:  J Gen Virol       Date:  1991-08       Impact factor: 3.891

3.  Recurring theme of changes in the transcriptional control region of BK virus during adaptation to cell culture.

Authors:  R Rubinstein; B C Schoonakker; E H Harley
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Two target sites for protein binding in the promoter region of a cell cycle regulated human H1 histone gene.

Authors:  A J van Wijnen; K L Wright; R F Massung; M Gerretsen; J L Stein; G S Stein
Journal:  Nucleic Acids Res       Date:  1988-01-25       Impact factor: 16.971

5.  cis-acting negative regulatory element of prolactin gene.

Authors:  Z X Zhang; V Kumar; R T Rivera; J Chisholm; D K Biswas
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

6.  Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts.

Authors:  I Davidson; C Fromental; P Augereau; A Wildeman; M Zenke; P Chambon
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

7.  Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription.

Authors:  J Drouin; M A Trifiro; R K Plante; M Nemer; P Eriksson; O Wrange
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

8.  Simian virus 40-like DNA sequences in human pleural mesothelioma.

Authors:  M Carbone; H I Pass; P Rizzo; M Marinetti; M Di Muzio; D J Mew; A S Levine; A Procopio
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

9.  BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions.

Authors:  A Sundsfjord; T Flaegstad; R Flø; A R Spein; M Pedersen; H Permin; J Julsrud; T Traavik
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

10.  Identification of positive and negative regulatory elements governing cell-type-specific expression of the neural cell adhesion molecule gene.

Authors:  M R Hirsch; L Gaugler; H Deagostini-Bazin; L Bally-Cuif; C Goridis
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

View more
  26 in total

1.  Phylogenetic analysis of polyomavirus BK sequences.

Authors:  Preety M Sharma; Gaurav Gupta; Abhay Vats; Ron Shapiro; Parmjeet Randhawa
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 2.  Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small T-antigens.

Authors:  U Moens; O M Seternes; B Johansen; O P Rekvig
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors.

Authors:  O P Rekvig; U Moens; A Sundsfjord; G Bredholt; A Osei; H Haaheim; T Traavik; E Arnesen; H J Haga
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

4.  Stimulation of BK virus DNA replication by NFI family transcription factors.

Authors:  Bo Liang; Irina Tikhanovich; Heinz Peter Nasheuer; William R Folk
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

5.  A system for the analysis of BKV non-coding control regions: application to clinical isolates from an HIV/AIDS patient.

Authors:  Nicole M Broekema; Johanna R Abend; Shauna M Bennett; Janet S Butel; John A Vanchiere; Michael J Imperiale
Journal:  Virology       Date:  2010-09-24       Impact factor: 3.616

6.  Restriction of human polyomavirus BK virus DNA replication in murine cells and extracts.

Authors:  Cathal Mahon; Bo Liang; Irina Tikhanovich; Johanna R Abend; Michael J Imperiale; Heinz P Nasheuer; William R Folk
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  Transcriptional regulation of BK virus by nuclear factor of activated T cells.

Authors:  Joslynn A Jordan; Kate Manley; Aisling S Dugan; Bethany A O'Hara; Walter J Atwood
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

8.  High reactivation of BK virus variants in Asian Indians with renal disorders and during pregnancy.

Authors:  Saumen Bhattacharjee; Tushar Chakraborty
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

9.  High frequency and diversity of rearrangements in polyomavirus bk noncoding regulatory regions cloned from urine and plasma of Israeli renal transplant patients and evidence for a new genetic subtype.

Authors:  Tsachi Tsadok Perets; Ilana Silberstein; Jana Rubinov; Ronit Sarid; Ella Mendelson; Lester M Shulman
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

10.  miRNA regulation of BK polyomavirus replication during early infection.

Authors:  Nicole M Broekema; Michael J Imperiale
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.